User profiles for Andrea Angheben

Andrea Angheben

Department of Infectious, Tropical Diseases and Microbiology - Hospital Sacro Cuore …
Verified email at sacrocuore.it
Cited by 7124

[HTML][HTML] Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 …

…, M Fantoni, I Kalomenidis, G Chrysos, A Angheben… - Nature medicine, 2021 - nature.com
Early increase of soluble urokinase plasminogen activator receptor (suPAR) serum levels is
indicative of increased risk of progression of coronavirus disease 2019 (COVID-19) to …

Effect of tocilizumab vs standard care on clinical worsening in patients hospitalized with COVID-19 pneumonia: a randomized clinical trial

…, V Del Bono, PL Colombelli, A Angheben… - JAMA internal …, 2021 - jamanetwork.com
Importance The coronavirus disease 2019 (COVID-19) pandemic is threatening billions of
people worldwide. Tocilizumab has shown promising results in retrospective studies in …

[HTML][HTML] Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis

…, M Fantoni, A Cingolani, A Angheben… - The Lancet …, 2021 - thelancet.com
Background Anakinra might improve the prognosis of patients with moderate to severe
COVID-19 (ie, patients requiring oxygen supplementation but not yet receiving organ support). …

[HTML][HTML] Severe strongyloidiasis: a systematic review of case reports

D Buonfrate, A Requena-Mendez, A Angheben… - BMC infectious …, 2013 - Springer
Background Strongyloidiasis is commonly a clinically unapparent, chronic infection, but
immuno suppressed subjects can develop fatal disease. We carried out a review of literature on …

Chagas disease in European countries: the challenge of a surveillance system

…, Y Carlier, DD Salamanca, A Angheben… - …, 2011 - eurosurveillance.org
A study of aggregate data collected from the literature and official sources was undertaken
to estimate expected and observed prevalence of Trypanosoma cruzi infection, annual …

[HTML][HTML] Diagnostic Accuracy of Five Serologic Tests for Strongyloides stercoralis Infection

…, M Gobbo, S Bonafini, A Angheben… - PLoS neglected …, 2014 - journals.plos.org
Background The diagnosis of Strongyloides stercoralis (S. stercoralis) infection is hampered
by the suboptimal sensitivity of fecal-based tests. Serological methods are believed to be …

[HTML][HTML] Accuracy of molecular biology techniques for the diagnosis of Strongyloides stercoralis infection—A systematic review and meta-analysis

…, A Requena-Mendez, A Angheben… - PLoS neglected …, 2018 - journals.plos.org
Background Strongyloides stercoralis infection is a neglected tropical disease which can
lead to severe symptoms and even death in immunosuppressed people. Unfortunately, its …

[HTML][HTML] Chagas disease and transfusion medicine: a perspective from non-endemic countries

A Angheben, L Boix, D Buonfrate, F Gobbi… - Blood …, 2015 - ncbi.nlm.nih.gov
In the last decades, increasing international migration and travel from Latin America to Europe
have favoured the emergence of tropical diseases outside their “historical” boundaries. …

[HTML][HTML] Congenital Chagas disease: updated recommendations for prevention, diagnosis, treatment, and follow-up of newborns and siblings, girls, women of …

Y Carlier, J Altcheh, A Angheben, H Freilij… - PLoS neglected …, 2019 - journals.plos.org
In 2005, the World Health Organization (WHO) recognized Chagas disease (CD; Trypanosoma
cruzi infection) as a neglected tropical disease (NTD)[1] and included it into the global …

[HTML][HTML] Health policies to control Chagas disease transmission in European countries

…, P Albajar-Viñas, A Angheben… - PLoS neglected …, 2014 - journals.plos.org
Chagas disease (CD) is a highly prevalent parasitic disease in immigrants from Mexico, as
well as all of Central and South America. The total number of infected people is estimated …